Please assess the completion status of the following clinical trial:

Trial Title: PROmotion of FLU Vaccine Uptake in the Emergency Department - PROFLUVAXED

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Adults~2. Presenting to ED~3. Not already vaccinated for influenza in the current year~4. Able to provide informed consent~5. Fluent in English or Spanish~6. Anticipated ability to complete study intervention in ED i.e., able to watch a 3-minute videoclip~Exclusion Criteria:~1. Age \< 18 years~2. Major trauma such that it will preclude survey~3. Inability to participate in a survey because of intoxication, altered mental status, or critical illness~4. Incarceration~5. Psychiatric hold~6. We will also exclude patients who state that they have already received an influenza vaccine and patients who are in the ED for suspected acute Covid or influenza illness.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Question (Q) (Type: EXPERIMENTAL): Subjects receive no vaccine messaging, but are asked a question about whether they would accept a vaccine
- Messaging (M) (Type: EXPERIMENTAL): Subjects receive vaccine messaging and are asked a question about whether they would accept a vaccine
- Non intervention (Type: NO_INTERVENTION): Usual care

Based on this trial design, predict the completion outcome and termination type (if applicable).